Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Cyber Monday Deal: Up to 60% off InvestingPro
CLAIM SALE
Puma Biotechnology Inc (PBYI)
Add to/Remove from a Portfolio
Add to Watchlist
3.200
-0.190
-5.60%
02:29:59 - Closed. Currency in USD
After Hours
3.200
-0.000
-0.000%
6:27:17 - Real-time Data
Type:
Equity
Market:
United States
- Volume: 752,992
- Bid/Ask: 0.000 / 0.000
- Day's Range: 3.180 - 3.480
Puma Biotech
3.200
-0.190
-5.60%
- Discussions
- Recent Sentiments
- User Rankings
PBYI User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Puma Biotechnology Inc share.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Robbert Kuipers | 1 | 1 | 1 | 100 | +318.59% |
| 2 | Reuben Johnson | 1 | 1 | 1 | 100 | +315.91% |
| 3 | Lukas Hajek | 2 | 1 | 1 | 100 | +307.13% |
| 4 | Simon Lee | 1 | 1 | 1 | 100 | +297.85% |
| 5 | Christopher Muñoz | 1 | 1 | 1 | 100 | +294.63% |
| 6 | Jimi Garnier | 1 | 1 | 1 | 100 | +288.34% |
| 7 | Magdy Samy | 1 | 1 | 1 | 100 | +286.79% |
| 8 | Mahmoud Sarhan | 3 | 3 | 1 | 33.33 | +282.73% |
| 9 | maris ozols | 1 | 1 | 1 | 100 | +258.33% |
| 10 | גבע הוכמן | 2 | 2 | 1 | 50 | +248.93% |
| 11 | Ignazio Mosca | 1 | 1 | 1 | 100 | +237.08% |
| 12 | Kubanychbek Asylbekov | 1 | 1 | 1 | 100 | +236.36% |
| 13 | Martin Petersen | 1 | 1 | 1 | 100 | +208.51% |
| 14 | Option Trader | 1 | 1 | 1 | 100 | +100% |
| 15 | Josema Campos | 1 | 1 | 1 | 100 | +82.22% |
| 16 | Pavel Ilin | 1 | 1 | 1 | 100 | +80.7% |
| 17 | arie Sklar | 1 | 1 | 1 | 100 | +69.72% |
| 18 | Lee Ai | 2 | 2 | 2 | 100 | +47.9% |
| 19 | Bala Pala | 21 | 21 | 15 | 71.43 | +41.35% |
| 20 | Celso Filipe Martins | 1 | 1 | 1 | 100 | +39.49% |
| 21 | davide garulli | 2 | 2 | 1 | 50 | +29.48% |
| 22 | ramon ramirez | 1 | 1 | 1 | 100 | +29.42% |
| 23 | Vasko Kotsev | 1 | 1 | 1 | 100 | +29.24% |
| 24 | Сергей Воробьев | 1 | 1 | 1 | 100 | +28.24% |
| 25 | Eniel Gonzalez | 5 | 5 | 2 | 40 | +27.75% |
| 26 | Federico Rodenas | 1 | 1 | 1 | 100 | +22.74% |
| 27 | Anthony Santos | 1 | 1 | 1 | 100 | +18.81% |
| 28 | Mario Alberto Bertocchi | 1 | 1 | 1 | 100 | +18.45% |
| 29 | Miguel Clos Uribe | 1 | 1 | 1 | 100 | +17.46% |
| 30 | 일환 이 | 1 | 1 | 1 | 100 | +16.97% |
| 31 | Sunil Anand | 1 | 1 | 1 | 100 | +16.44% |
| 32 | Yeoshua Syrquin | 1 | 1 | 1 | 100 | +15.88% |
| 33 | Валерий Гусев | 2 | 2 | 1 | 50 | +12.99% |
| 34 | Claudinho Rodrigues | 1 | 1 | 1 | 100 | +12.65% |
| 35 | thekeystonegamer thorpe | 1 | 1 | 1 | 100 | +12.32% |
| 36 | Awais Anwar | 1 | 1 | 1 | 100 | +11% |
| 37 | Bun Ly | 1 | 1 | 1 | 100 | +10.07% |
| 38 | Danil Ho | 1 | 1 | 1 | 100 | +8.99% |
| 39 | Eden Izhak Hemo | 1 | 1 | 1 | 100 | +8.42% |
| 40 | Asif Mohamed | 1 | 1 | 1 | 100 | +7.17% |
| 41 | Семен Чайковский | 1 | 1 | 1 | 100 | +6.05% |
| 42 | Aleksi Jurvanen | 2 | 1 | 1 | 100 | +4.83% |
| 43 | Nicola Bracale | 3 | 2 | 1 | 50 | +4.75% |
| 44 | Robbert Kuipers | 1 | 1 | 1 | 100 | +4.55% |
| 45 | Michael ROUX | 1 | 1 | 1 | 100 | +4.3% |
| 46 | Szymon Formela | 1 | 1 | 1 | 100 | +4.29% |
| 47 | Elio Giudice | 1 | 1 | 1 | 100 | +3.83% |
| 48 | chelsea wang | 1 | 1 | 1 | 100 | +3.5% |
| 49 | Bert Rogmans | 1 | 1 | 1 | 100 | +3.31% |
| 50 | Itamar Haim | 1 | 1 | 1 | 100 | +1.2% |
Write your thoughts about Puma Biotechnology Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review